StockData
Neurogene Inc. logo

Neurogene Inc. (NGNE) stock

NGNENasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 6/30
$23.14+0.04 (+0.17%)

Close on Nov 18, 2026Market cap $463.06MP/E –Yield –

Neurogene price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Neurogene's price to sales ratio was 240.9× on Apr 30, 2025.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2025Apr 30, 2025240.9×+230.8
2019Apr 30, 201910.1×–

More Neurogene figures

See a number that looks wrong?